MGBX held its first English Twitter Space on August 28, sharing market insights and trading strategies with global users. The guest speaker was Crypto Blood, a creator in the crypto space known for his sharp market analysis and pragmatic trading approach, which has garnered significant attention in the community.
At the beginning, the host briefly reviewed the evolution of MGBX's products since 2019: spot trading, contracts, and AI copy trading have been continuously improved, and recently, the smart copy trading system and interface have been revamped to provide users with a smoother trading experience. Additionally, during this Space, MGBX officially announced its participation in TOKEN2049 in Singapore, aiming to engage with more overseas users in person.
The discussion in this Space revolved around CryptoBlood's personal experiences, his views on the market, and his advice for investors. The atmosphere was lively, and the pace was tight, with Q&A interactions continuously driving the topics deeper.
CryptoBlood started by discussing his personal journey, introducing how he entered the crypto space and the motivation behind founding Bloodalytics. He entered the crypto market in 2013, having previously accumulated a systematic methodology in the U.S. stock and forex markets; leveraging his software engineering background, he initially engaged in semi-automated trading using EA (Expert Advisor) on MT4. As early tools in crypto were relatively scarce, he later turned to TradingView, using Pine Script to solidify the rules of "entry - stop loss - partial profit taking," continuously iterating and refining to create what is now Bloodalytics. This not only provided him with a reliable and verifiable set of quantitative signals but also allowed others to use it directly, avoiding unnecessary detours.
Next, CryptoBlood shared his advice for beginners in trading. He mentioned that the most common issue for newcomers is the confusion between the boundaries of "investment" and "trading," as well as a lack of strict stop-loss measures and systematic methods. To overcome these pitfalls, the key is to first build and validate an executable system (backtesting + forward testing) and prioritize risk management.
Following this, the host and CryptoBlood discussed the current market environment.
CryptoBlood provided his assessment of the current market stage: institutionalization is deepening, and the correlation with U.S. stocks has significantly increased, with funds like ETFs dominating the short-term rhythm, making structural differentiation more common. In the early days, the correlation between crypto and Wall Street was low, but as participants increased and ETFs launched, more funds came from Wall Street, leading to more frequent portfolio rebalancing—when the stock market is underperforming, funds may sell cryptocurrencies to hedge losses or free up cash. Therefore, he considers Nasdaq futures to be an index he checks daily, believing that the Nasdaq has a higher correlation with the crypto market compared to the S&P 500.
He also mentioned a change: Ethereum has relatively strengthened and has temporarily "decoupled" from Bitcoin. In his years of observation, such a magnitude is rare, and it seems to reflect a rotation of funds from Bitcoin to Ethereum ETFs, while the market is re-pricing the risks associated with large BTC holders. In extreme cases, being forced to liquidate some positions could trigger a chain reaction in prices. Before the stock market shows clear signs of weakness, he tends to favor a phase where Ethereum is relatively dominant; however, once the U.S. stock market turns, he warns that the transmission of risk assets falling together requires vigilance. From the perspectives of short-term trading and long-term investment, CryptoBlood believes that short-term traders only need volatility and can find opportunities in both bullish and bearish scenarios with a system; long-term investors, on the other hand, are more susceptible to drawdowns and need to maintain cash buffers to invest in batches at lower positions. He emphasized that the choice of method can vary from person to person, but risk management is the decisive factor for the ultimate experience.
Finally, the host and CryptoBlood discussed the competition among trading platforms and CryptoBlood's experience collaborating with MGBX.
CryptoBlood summarized the standards for a "good platform" into a few key aspects: stability and fairness (accurate quotes/charts, no disconnections, no "stop loss hunting"), security and operations, and time validation. Regarding the essence of contract trading, he believes the core still lies in risk control/fund management/execution discipline, which have always been prioritized in his long-term practice.
About his collaboration with MGBX, CryptoBlood expressed a positive experience so far and mentioned that the main reason for choosing to collaborate was the platform's openness in copy trading and the reliability of its product refinement. He also looks forward to integrating low-risk HedgeLytics signals into the copy trading scenario and further exploring synergies in wealth management and other areas.
At the end of the event, the host emphasized that MGBX will continue to optimize its products, accelerate the development of spot trading and liquidity building, improve the copy trading system, and further enhance user experience. For more updates and event information, please visit the official website https://www.mgbx.com/ or follow the official X account @MGBX_EN for the latest updates; MGBX responds to expectations with continuous iteration and global layout, and fulfills its commitments through action—not just trading, but focusing on long-term companionship.
The information is sourced from MGBX and is for informational sharing only, not constituting any investment advice.
免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。
